AustVASociety
898 posts

AustVASociety
@AVASociety
AVAS was established for vascular access clinicians to network & develop the specialty through research, practice & education. Posts by the AVAS Executive Team.
Sydney, Australia Katılım Temmuz 2013
143 Takip Edilen965 Takipçiler

VeinTech are an Australian-based medical device company looking to better understand one of the key procedures you perform as a qualified healthcare provider: starting an IV.
Please click the link below to start the survey:
forms.office.com/r/Ek24XwCBHS

English

We are incredibly proud of AVAS members @a_ullman and @Claire_AVATAR on this outstanding achievement. This research will contribute to reducing CVC complications in children with cancer. Well done Amanda and Claire!
Amanda Ullman@amanda_ullman
I am honoured & excited by the investment from @nhmrc as an IG to reduce CVC complications for kids w cancer & build capacity for the future. I am also excited that we get to DO the research, rather than PROPOSE the research, for the next 5 years. @UQHealth @childhealthqld
English
AustVASociety retweetledi

Do you want to do a fully funded PhD to improve one of the fastest growing sectors in health?
👇
Join us @RBRCUniSA for a project to develop better support mechanisms for caregivers of people having intravenous antibiotics at home.
Further details here unisa.edu.au/research/degre…
English

Journal Alert! AVAS has partnered with the Canadian Vascular Access Association. AVAS Members can now disseminate their work and access a broader range of leading-edge theories, developments, research, and practices: avas.org.au/vascular-acces…
English

SA AVAS would like to thank @FloMedical for supporting our event this evening.
Great turnout from clinicians interested in Vascular Access.
English

@reb_sharp looking at needs framework for living with PICC. What are patient needs?
English

PICC: catheter to vein ration (CVR) can increase thrombus risk. @reb_sharp suggests <45% CVR reduces risk. CVR >45% doubles risk.
English












